Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-12-19 Purchase | 2025-12-22 07:07 am | Evommune Inc. | EVMN | Hopfner Robert Lorne Director 10% Owner | 1,000 | $17.35 | $17,350 | 3,372,001 (Indirect) | View |
| 2025-11-07 Purchase | 2025-11-12 4:26 pm | Evommune Inc. | EVMN | RA CAPITAL MANAGEMENT L.P. Director 10% Owner | 1,250,000 | $16 | $20,000,000 | 784,345 (Indirect) | View |
| 2025-11-07 Purchase | 2025-11-12 4:25 pm | Evommune Inc. | EVMN | LSP 7 Cooperative UA 10% Owner | 1,562,500 | $16 | $25,000,000 | 4,929,633 (Direct) | View |
| 2025-11-07 Purchase | 2025-11-12 4:24 pm | Evommune Inc. | EVMN | Verduyn-van Weegen Felice Isabel Director 10% Owner | 1,562,500 | $16 | $25,000,000 | 4,929,633 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-17 Option Award | 2026-02-19 4:30 pm | N/A N/A | Evommune Inc. | EVMN | LSP 7 Cooperative UA Director 10% Owner | 358,680 | $27.88 | 5,288,313 (Indirect) | View |
| 2026-02-17 Option Award | 2026-02-18 9:19 pm | N/A N/A | Evommune Inc. | EVMN | Verduyn-van Weegen Felice Isabel Director 10% Owner | 358,680 | $27.88 | 5,288,313 (Indirect) | View |
| 2026-02-17 Option Award | 2026-02-17 7:28 pm | N/A N/A | Evommune Inc. | EVMN | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director | 35,868 | $27.88 | 3,494,638 (Indirect) | View |
| 2025-12-08 Option Award | 2025-12-19 4:06 pm | N/A 2035-12-08 | Evommune Inc. | EVMN | Bauer Eugene Chief Medical Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2025-12-09 Tax Withholding | 2025-12-11 4:23 pm | N/A N/A | Evommune Inc. | EVMN | Pena Luis C. President & CEO | 28,138 | $17.84 | 654,683 (Direct) | View |
| 2025-12-09 Tax Withholding | 2025-12-11 4:22 pm | N/A N/A | Evommune Inc. | EVMN | Patel Jeegar Pravinkumar Chief Scientific Officer | 7,513 | $17.84 | 49,578 (Direct) | View |
| 2025-12-09 Tax Withholding | 2025-12-11 4:22 pm | N/A N/A | Evommune Inc. | EVMN | Moss Gregory S. Chief Business & Legal Officer | 13,624 | $17.84 | 64,010 (Direct) | View |
| 2025-12-09 Tax Withholding | 2025-12-11 4:21 pm | N/A N/A | Evommune Inc. | EVMN | Drew Janice Suzann EVP, Operations | 5,074 | $17.84 | 67,794 (Direct) | View |
| 2025-12-09 Tax Withholding | 2025-12-11 4:20 pm | N/A N/A | Evommune Inc. | EVMN | Carver Kyle Chief Financial Officer | 13,290 | $17.84 | 62,510 (Direct) | View |
| 2025-12-09 Tax Withholding | 2025-12-11 4:18 pm | N/A N/A | Evommune Inc. | EVMN | Bauer Eugene Chief Medical Officer | 1,478 | $17.84 | 270,818 (Direct) | View |
| 2025-11-07 Conversion | 2025-11-12 4:46 pm | N/A N/A | Evommune Inc. | EVMN | Pivotal bioVenture Partners Fund I L.P. Pivotal bioVenture Partners Fund I G.P. L.P. Pivotal bioVenture Partners Fund I U.G.P. Ltd Director 10% Owner | 31,034,681 | $0 | 294,502 (Indirect) | View |
| 2025-11-07 Conversion | 2025-11-12 4:26 pm | N/A N/A | Evommune Inc. | EVMN | RA CAPITAL MANAGEMENT L.P. Director 10% Owner | 21,023,089 | $0 | 784,345 (Indirect) | View |
| 2025-11-07 Conversion | 2025-11-12 4:25 pm | N/A N/A | Evommune Inc. | EVMN | LSP 7 Cooperative UA 10% Owner | 30,535,610 | $0 | 4,929,633 (Direct) | View |
| 2025-11-07 Conversion | 2025-11-12 4:24 pm | N/A N/A | Evommune Inc. | EVMN | Verduyn-van Weegen Felice Isabel Director 10% Owner | 30,535,610 | $0 | 4,929,633 (Indirect) | View |
| 2025-11-07 Conversion | 2025-11-12 4:22 pm | N/A N/A | Evommune Inc. | EVMN | Pena Luis C. President & CEO | 230,580 | $0 | 682,821 (Direct) | View |
| 2025-11-07 Conversion | 2025-11-12 4:21 pm | N/A N/A | Evommune Inc. | EVMN | Patel Jeegar Pravinkumar Chief Scientific Officer | 28,175 | $0 | 57,091 (Direct) | View |
| 2025-11-07 Conversion | 2025-11-12 4:20 pm | N/A N/A | Evommune Inc. | EVMN | Moss Gregory S. Chief Business & Legal Officer | 28,175 | $0 | 77,634 (Indirect) | View |
| 2025-11-07 Conversion | 2025-11-12 4:19 pm | N/A N/A | Evommune Inc. | EVMN | Hopfner Robert Lorne Director 10% Owner | 31,063,497 | $0 | 294,502 (Indirect) | View |
| 2025-11-07 Conversion | 2025-11-12 4:18 pm | N/A N/A | Evommune Inc. | EVMN | Drew Janice Suzann EVP, Operations | 14,087 | $0 | 72,868 (Direct) | View |
| 2025-11-07 Conversion | 2025-11-12 4:17 pm | N/A N/A | Evommune Inc. | EVMN | Cohen David E Director | 57,644 | $0 | 23,665 (Direct) | View |
| 2025-11-07 Conversion | 2025-11-12 4:16 pm | N/A N/A | Evommune Inc. | EVMN | Carver Kyle Chief Financial Officer | 28,175 | $0 | 75,800 (Direct) | View |
| 2025-11-07 Conversion | 2025-11-12 4:15 pm | N/A N/A | Evommune Inc. | EVMN | Bauer Eugene Chief Medical Officer | 244,667 | $0 | 272,296 (Direct) | View |
| 2025-11-05 Option Award | 2025-11-07 4:15 pm | N/A 2035-11-04 | Evommune Inc. | EVMN | Cohen David E Director | 37,960 | $0 | 37,960 (Direct) | View |
| 2025-11-05 Option Award | 2025-11-07 4:15 pm | N/A 2035-11-04 | Evommune Inc. | EVMN | KIRSCH ARTHUR S Director | 37,960 | $0 | 37,960 (Direct) | View |
| 2025-11-05 Option Award | 2025-11-07 4:15 pm | N/A 2035-11-04 | Evommune Inc. | EVMN | MCGRAW BENJAMIN F III Director | 37,960 | $0 | 37,960 (Direct) | View |
| 2025-11-05 Option Award | 2025-11-07 4:15 pm | N/A 2035-11-04 | Evommune Inc. | EVMN | Patel Jeegar Pravinkumar Chief Scientific Officer | 179,619 | $0 | 179,619 (Direct) | View |
| 2025-11-05 Option Award | 2025-11-07 4:15 pm | N/A 2035-11-04 | Evommune Inc. | EVMN | Drew Janice Suzann EVP, Operations | 231,274 | $0 | 231,274 (Direct) | View |
| 2025-11-05 Option Award | 2025-11-07 4:15 pm | N/A 2035-11-04 | Evommune Inc. | EVMN | Carver Kyle Chief Financial Officer | 279,408 | $0 | 279,408 (Direct) | View |
| 2025-11-05 Option Award | 2025-11-07 4:15 pm | N/A 2035-11-04 | Evommune Inc. | EVMN | Pena Luis C. President & CEO | 796,841 | $0 | 796,841 (Direct) | View |
| 2025-11-05 Option Award | 2025-11-07 4:15 pm | N/A 2035-11-04 | Evommune Inc. | EVMN | Moss Gregory S. Chief Business & Legal Officer | 293,496 | $0 | 293,496 (Direct) | View |
Ownership | 2025-11-05 8:13 pm | N/A N/A | Evommune Inc. | EVMN | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 0 | $0 | 2,208,770 (Indirect) | View |
Ownership | 2025-11-05 8:12 pm | N/A N/A | Evommune Inc. | EVMN | LSP 7 Cooperative UA 10% Owner | 0 | $0 | 3,367,133 (Direct) | View |
Ownership | 2025-11-05 8:11 pm | N/A N/A | Evommune Inc. | EVMN | Pivotal bioVenture Partners Fund I L.P. Pivotal bioVenture Partners Fund I G.P. L.P. Pivotal bioVenture Partners Fund I U.G.P. Ltd Director 10% Owner | 0 | $0 | 3,367,975 (Indirect) | View |
Ownership | 2025-11-05 8:11 pm | N/A N/A | Evommune Inc. | EVMN | Verduyn-van Weegen Felice Isabel Director 10% Owner | 0 | $0 | 3,367,133 (Indirect) | View |
Ownership | 2025-11-05 8:10 pm | N/A N/A | Evommune Inc. | EVMN | Pena Luis C. President & CEO | 0 | $0 | 2,132,020 (Direct) | View |
Ownership | 2025-11-05 8:09 pm | N/A N/A | Evommune Inc. | EVMN | Patel Jeegar Pravinkumar Chief Scientific Officer | 0 | $0 | 299,134 (Direct) | View |
Ownership | 2025-11-05 8:08 pm | N/A N/A | Evommune Inc. | EVMN | Moss Gregory S. Chief Business & Legal Officer | 0 | $0 | 496,819 (Direct) | View |
Ownership | 2025-11-05 8:07 pm | N/A 2030-10-13 | Evommune Inc. | EVMN | MCGRAW BENJAMIN F III Director | 0 | $0 | 99,507 (Direct) | View |